Synektik S.A.
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more
Market Cap & Net Worth: Synektik S.A. (SNT)
Synektik S.A. (WAR:SNT) has a market capitalization of $553.01 Million (zł2.30 Billion) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #13458 globally and #39 in its home market, demonstrating a -3.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Synektik S.A.'s stock price zł269.60 by its total outstanding shares 8529129 (8.53 Million).
Synektik S.A. Market Cap History: 2015 to 2026
Synektik S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $33.69 Million to $553.01 Million (32.32% CAGR).
Index Memberships
Synektik S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$22.01 Billion | 1.22% | #18 of 40 |
Weight: Synektik S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Synektik S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Synektik S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.85x
Synektik S.A.'s market cap is 0.85 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
5.63x
Synektik S.A.'s market cap is 5.63 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $29.55 Million | $49.43 Million | $388.09K | 0.60x | 76.15x |
| 2017 | $31.61 Million | $62.94 Million | $4.09 Million | 0.50x | 7.74x |
| 2018 | $16.66 Million | $105.32 Million | $10.29 Million | 0.16x | 1.62x |
| 2019 | $28.82 Million | $134.79 Million | $9.14 Million | 0.21x | 3.15x |
| 2020 | $52.35 Million | $125.39 Million | $8.81 Million | 0.42x | 5.94x |
| 2021 | $56.26 Million | $128.63 Million | $8.38 Million | 0.44x | 6.71x |
| 2022 | $58.30 Million | $166.86 Million | $10.30 Million | 0.35x | 5.66x |
| 2023 | $172.36 Million | $446.87 Million | $52.45 Million | 0.39x | 3.29x |
| 2024 | $407.37 Million | $624.12 Million | $84.64 Million | 0.65x | 4.81x |
| 2025 | $579.67 Million | $681.60 Million | $102.93 Million | 0.85x | 5.63x |
Competitor Companies of SNT by Market Capitalization
Companies near Synektik S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Synektik S.A. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Synektik S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Synektik S.A.'s market cap moved from $33.69 Million to $ 553.01 Million, with a yearly change of 32.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł553.01 Million | -4.60% |
| 2025 | zł579.67 Million | +42.30% |
| 2024 | zł407.37 Million | +136.36% |
| 2023 | zł172.36 Million | +195.62% |
| 2022 | zł58.30 Million | +3.62% |
| 2021 | zł56.26 Million | +7.47% |
| 2020 | zł52.35 Million | +81.63% |
| 2019 | zł28.82 Million | +73.03% |
| 2018 | zł16.66 Million | -47.31% |
| 2017 | zł31.61 Million | +6.97% |
| 2016 | zł29.55 Million | -12.28% |
| 2015 | zł33.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Synektik S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $553.01 Million USD |
| MoneyControl | $553.01 Million USD |
| MarketWatch | $553.01 Million USD |
| marketcap.company | $553.01 Million USD |
| Reuters | $553.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.